Showing results (1811-1820 of 1,908) with videos related to
Sort By:
Pageof 191
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 27, 2025
Recurrence rate, features, and outcome after hepatocellular carcinoma curative resection or ablation according to the IMbrave050 criteria: a real-world studyEdoardo G Giannini, Andrea Pasta, Laura Bucci, et al.Journal of Hepatology|February 14, 2017
Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinomaGiuseppe Cabibbo, Salvatore Petta, Marco Barbara, et al.Cell|December 18, 2007
Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancerKlarisa Rikova, Ailan Guo, Qingfu Zeng, et al.Iscience|March 4, 2025
DNA-PK inhibition sustains the antitumor innate immune response in small cell lung cancerCaterina De Rosa, Floriana Morgillo, Luisa Amato, et al.Liver International : Official Journal of the International Association for the Study of the Liver|November 21, 2020
The changing scenario of hepatocellular carcinoma in Italy: an updateFrancesca Garuti, Andrea Neri, Francesca Avanzato, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 7, 2018
Increased Prevalence of Rare Sucrase-isomaltase Pathogenic Variants in Irritable Bowel Syndrome PatientsKoldo Garcia-Etxebarria, Tenghao Zheng, Ferdinando Bonfiglio, et al.Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|January 6, 2020
Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014-2018)Jean-Pascal Lefaucheur, André Aleman, Chris Baeken, et al.Hepatology International|March 25, 2025
Systemic inflammatory response markers improve the discrimination for prognostic model in hepatocellular carcinomaAlba Rocco, Costantino Sgamato, Filippo Pelizzaro, et al.Contemporary Clinical Trials|April 18, 2024
D3/Penta 21 clinical trial design: A randomised non-inferiority trial with nested drug licensing substudy to assess dolutegravir and lamivudine fixed dose formulations for the maintenance of virological suppression in children with HIV-1 infection, aged 2 to 15 yearsAnna Turkova, Man K Chan, Cissy Kityo, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 23, 2020
Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter studyGiovanni Marasco, Antonio Colecchia, Maria Letizia Bacchi Reggiani, et al.Pageof 191